Listed

Eledon Pharmaceuticals, Inc.

ELDNNasdaqCIK 1404281HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$22.9m, Q2 FY2026
Net income−$31.6m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m7.9Research and development, Q3 FY2023, three months to 2023-09-30$7.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125622.Report this figure7.1Research and development, Q4 FY2023, three months to 2023-12-31$7.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K/A filed 2025-08-14, accession 0001193125-25-180865. Derived: 12-month figure less the 9-month figure.Report this figure7.4Research and development, Q1 FY2024, three months to 2024-03-31$7.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q/A filed 2025-08-14, accession 0001193125-25-180904.Report this figure10.1Research and development, Q2 FY2024, three months to 2024-06-30$10.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001193125-25-180906.Report this figure16.5Research and development, Q3 FY2024, three months to 2024-09-30$16.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figure17.9Research and development, Q4 FY2024, three months to 2024-12-31$17.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001193125-26-116164. Derived: 12-month figure less the 9-month figure.Report this figure13.5Research and development, Q1 FY2025, three months to 2025-03-31$13.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001193125-26-221702.Report this figure20.3Research and development, Q2 FY2025, three months to 2025-06-30$20.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure15.0Research and development, Q3 FY2025, three months to 2025-09-30$15.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figure17.5Research and development, Q4 FY2025, three months to 2025-12-31$17.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001193125-26-116164. Derived: 12-month figure less the 9-month figure.Report this figure17.2Research and development, Q1 FY2026, three months to 2026-03-31$17.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001193125-26-221702.Report this figure18.2Research and development, Q2 FY2026, three months to 2026-06-30$18.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure
Operating income$m(11.2)Operating income, Q3 FY2023, three months to 2023-09-30−$11.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125622.Report this figure(10.3)Operating income, Q4 FY2023, three months to 2023-12-31−$10.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-03-28, accession 0000950170-24-038091. Derived: 12-month figure less the 9-month figure.Report this figure(10.9)Operating income, Q1 FY2024, three months to 2024-03-31−$10.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q/A filed 2025-08-14, accession 0001193125-25-180904.Report this figure(14.5)Operating income, Q2 FY2024, three months to 2024-06-30−$14.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001193125-25-180906.Report this figure(20.5)Operating income, Q3 FY2024, three months to 2024-09-30−$20.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figurenot reported(18.0)Operating income, Q1 FY2025, three months to 2025-03-31−$18.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001193125-26-221702.Report this figure(24.7)Operating income, Q2 FY2025, three months to 2025-06-30−$24.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure(19.1)Operating income, Q3 FY2025, three months to 2025-09-30−$19.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figurenot reported(21.2)Operating income, Q1 FY2026, three months to 2026-03-31−$21.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001193125-26-221702.Report this figure(22.9)Operating income, Q2 FY2026, three months to 2026-06-30−$22.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(9.9)Net income, Q3 FY2023, three months to 2023-09-30−$9.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125622.Report this figure(30.1)Net income, Q4 FY2023, three months to 2023-12-31−$30.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2025-08-14, accession 0001193125-25-180865. Derived: 12-month figure less the 9-month figure.Report this figure(23.6)Net income, Q1 FY2024, three months to 2024-03-31−$23.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figure(44.9)Net income, Q2 FY2024, three months to 2024-06-30−$44.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figure77.0Net income, Q3 FY2024, three months to 2024-09-30$77.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figure(44.6)Net income, Q4 FY2024, three months to 2024-12-31−$44.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-116164. Derived: 12-month figure less the 9-month figure.Report this figure(6.5)Net income, Q1 FY2025, three months to 2025-03-31−$6.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure(11.2)Net income, Q2 FY2025, three months to 2025-06-30−$11.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure(17.5)Net income, Q3 FY2025, three months to 2025-09-30−$17.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figure(10.4)Net income, Q4 FY2025, three months to 2025-12-31−$10.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-116164. Derived: 12-month figure less the 9-month figure.Report this figure(39.0)Net income, Q1 FY2026, three months to 2026-03-31−$39.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure(31.6)Net income, Q2 FY2026, three months to 2026-06-30−$31.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure
Diluted EPS$ per share(0.33)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-125622.Report this figurenot reported(0.65)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q/A filed 2025-08-14, accession 0001193125-25-180904.Report this figure(0.92)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.92 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001193125-25-180906.Report this figure(0.28)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figurenot reported(0.08)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001193125-26-221702.Report this figure(0.13)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure(0.21)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figurenot reported(0.33)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001193125-26-221702.Report this figure(0.27)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure
Basic EPS$ per share(0.33)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-125622.Report this figurenot reported(0.65)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.65 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q/A filed 2025-08-14, accession 0001193125-25-180904.Report this figure(0.92)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.92 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001193125-25-180906.Report this figure1.05Basic EPS, Q3 FY2024, three months to 2024-09-30$1.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figurenot reported(0.08)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001193125-26-221702.Report this figure(0.13)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure(0.21)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figurenot reported(0.33)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001193125-26-221702.Report this figure(0.27)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure

Balance sheet

Cash and equivalents$6.8m, Q2 FY2026
Shareholders' equity$33.0m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m3.7Cash and equivalents, Q3 FY2023, at 2023-09-30$3.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0000950170-23-062203.Report this figure4.6Cash and equivalents, FY2023, at 2023-12-31$4.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K/A filed 2025-08-14, accession 0001193125-25-180865.Report this figure5.7Cash and equivalents, Q1 FY2024, at 2024-03-31$5.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q/A filed 2024-08-19, accession 0000950170-24-098582.Report this figure26.0Cash and equivalents, Q2 FY2024, at 2024-06-30$26.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-19, accession 0000950170-24-098590.Report this figure6.8Cash and equivalents, Q3 FY2024, at 2024-09-30$6.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-125622.Report this figure20.5Cash and equivalents, FY2024, at 2024-12-31$20.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-19, accession 0001193125-26-116164.Report this figure8.5Cash and equivalents, Q1 FY2025, at 2025-03-31$8.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q/A filed 2025-08-14, accession 0001193125-25-180904.Report this figure5.7Cash and equivalents, Q2 FY2025, at 2025-06-30$5.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001193125-25-180906.Report this figure3.7Cash and equivalents, Q3 FY2025, at 2025-09-30$3.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figure22.8Cash and equivalents, FY2025, at 2025-12-31$22.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure6.2Cash and equivalents, Q1 FY2026, at 2026-03-31$6.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001193125-26-221702.Report this figure6.8Cash and equivalents, Q2 FY2026, at 2026-06-30$6.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure
Current assets$m63.0Current assets, Q3 FY2023, at 2023-09-30$63.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062203.Report this figure56.1Current assets, FY2023, at 2023-12-31$56.1m. XBRL concept us-gaap:AssetsCurrent. 10-K/A filed 2025-08-14, accession 0001193125-25-180865.Report this figure48.0Current assets, Q1 FY2024, at 2024-03-31$48.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q/A filed 2024-08-19, accession 0000950170-24-098582.Report this figure87.2Current assets, Q2 FY2024, at 2024-06-30$87.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-19, accession 0000950170-24-098590.Report this figure81.5Current assets, Q3 FY2024, at 2024-09-30$81.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125622.Report this figure144Current assets, FY2024, at 2024-12-31$143.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-19, accession 0001193125-26-116164.Report this figure128Current assets, Q1 FY2025, at 2025-03-31$127.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q/A filed 2025-08-14, accession 0001193125-25-180904.Report this figure111Current assets, Q2 FY2025, at 2025-06-30$111.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001193125-25-180906.Report this figure96.3Current assets, Q3 FY2025, at 2025-09-30$96.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figure136Current assets, FY2025, at 2025-12-31$135.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure114Current assets, Q1 FY2026, at 2026-03-31$113.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001193125-26-221702.Report this figure93.1Current assets, Q2 FY2026, at 2026-06-30$93.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure
Total assets$m96.1Total assets, Q3 FY2023, at 2023-09-30$96.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-062203.Report this figure89.1Total assets, FY2023, at 2023-12-31$89.1m. XBRL concept us-gaap:Assets. 10-K/A filed 2025-08-14, accession 0001193125-25-180865.Report this figure80.8Total assets, Q1 FY2024, at 2024-03-31$80.8m. XBRL concept us-gaap:Assets. 10-Q/A filed 2024-08-19, accession 0000950170-24-098582.Report this figure120Total assets, Q2 FY2024, at 2024-06-30$120.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-19, accession 0000950170-24-098590.Report this figure115Total assets, Q3 FY2024, at 2024-09-30$114.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-125622.Report this figure177Total assets, FY2024, at 2024-12-31$177.4m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-19, accession 0001193125-26-116164.Report this figure161Total assets, Q1 FY2025, at 2025-03-31$161.3m. XBRL concept us-gaap:Assets. 10-Q/A filed 2025-08-14, accession 0001193125-25-180904.Report this figure145Total assets, Q2 FY2025, at 2025-06-30$144.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001193125-25-180906.Report this figure130Total assets, Q3 FY2025, at 2025-09-30$129.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figure169Total assets, FY2025, at 2025-12-31$169.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure147Total assets, Q1 FY2026, at 2026-03-31$146.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001193125-26-221702.Report this figure126Total assets, Q2 FY2026, at 2026-06-30$126.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure
Current liabilities$m2.9Current liabilities, Q3 FY2023, at 2023-09-30$2.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062203.Report this figure3.9Current liabilities, FY2023, at 2023-12-31$3.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K/A filed 2025-08-14, accession 0001193125-25-180865.Report this figure4.2Current liabilities, Q1 FY2024, at 2024-03-31$4.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q/A filed 2024-08-19, accession 0000950170-24-098582.Report this figure6.0Current liabilities, Q2 FY2024, at 2024-06-30$6.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-19, accession 0000950170-24-098590.Report this figure12.5Current liabilities, Q3 FY2024, at 2024-09-30$12.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125622.Report this figure11.6Current liabilities, FY2024, at 2024-12-31$11.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-19, accession 0001193125-26-116164.Report this figure9.2Current liabilities, Q1 FY2025, at 2025-03-31$9.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q/A filed 2025-08-14, accession 0001193125-25-180904.Report this figure13.7Current liabilities, Q2 FY2025, at 2025-06-30$13.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001193125-25-180906.Report this figure14.3Current liabilities, Q3 FY2025, at 2025-09-30$14.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figure18.3Current liabilities, FY2025, at 2025-12-31$18.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure13.5Current liabilities, Q1 FY2026, at 2026-03-31$13.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001193125-26-221702.Report this figure11.8Current liabilities, Q2 FY2026, at 2026-06-30$11.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure
Total liabilities$m60.5Total liabilities, Q3 FY2023, at 2023-09-30$60.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-125622.Report this figure81.9Total liabilities, FY2023, at 2023-12-31$81.9m. XBRL concept us-gaap:Liabilities. 10-K/A filed 2025-08-14, accession 0001193125-25-180865.Report this figure95.5Total liabilities, Q1 FY2024, at 2024-03-31$95.5m. XBRL concept us-gaap:Liabilities. 10-Q/A filed 2024-08-19, accession 0000950170-24-098582.Report this figure129Total liabilities, Q2 FY2024, at 2024-06-30$129.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-19, accession 0000950170-24-098590.Report this figure38.5Total liabilities, Q3 FY2024, at 2024-09-30$38.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-125622.Report this figure59.3Total liabilities, FY2024, at 2024-12-31$59.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-19, accession 0001193125-26-116164.Report this figure46.7Total liabilities, Q1 FY2025, at 2025-03-31$46.7m. XBRL concept us-gaap:Liabilities. 10-Q/A filed 2025-08-14, accession 0001193125-25-180904.Report this figure38.9Total liabilities, Q2 FY2025, at 2025-06-30$38.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001193125-25-180906.Report this figure38.8Total liabilities, Q3 FY2025, at 2025-09-30$38.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figure32.2Total liabilities, FY2025, at 2025-12-31$32.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure46.2Total liabilities, Q1 FY2026, at 2026-03-31$46.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001193125-26-221702.Report this figure54.1Total liabilities, Q2 FY2026, at 2026-06-30$54.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure
Shareholders' equity$m35.6Shareholders' equity, Q3 FY2023, at 2023-09-30$35.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-125622.Report this figure(48.5)Shareholders' equity, FY2023, at 2023-12-31−$48.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-19, accession 0001193125-26-116164.Report this figure(70.4)Shareholders' equity, Q1 FY2024, at 2024-03-31−$70.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figure(64.2)Shareholders' equity, Q2 FY2024, at 2024-06-30−$64.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figure20.4Shareholders' equity, Q3 FY2024, at 2024-09-30$20.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figure62.4Shareholders' equity, FY2024, at 2024-12-31$62.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure58.9Shareholders' equity, Q1 FY2025, at 2025-03-31$58.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure50.3Shareholders' equity, Q2 FY2025, at 2025-06-30$50.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure35.4Shareholders' equity, Q3 FY2025, at 2025-09-30$35.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figure81.1Shareholders' equity, FY2025, at 2025-12-31$81.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure44.8Shareholders' equity, Q1 FY2026, at 2026-03-31$44.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure33.0Shareholders' equity, Q2 FY2026, at 2026-06-30$33.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure

Cash flow

Operating cash flow−$22.7m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(12.3)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$12.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-125622. Derived: 9-month figure less the 6-month figure.Report this figure(9.1)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$9.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K/A filed 2025-08-14, accession 0001193125-25-180865. Derived: 12-month figure less the 9-month figure.Report this figure(8.7)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$8.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q/A filed 2025-08-14, accession 0001193125-25-180904.Report this figure(7.8)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$7.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001193125-25-180906. Derived: 6-month figure less the 3-month figure.Report this figure(11.8)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$11.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001193125-25-283275. Derived: 9-month figure less the 6-month figure.Report this figure(19.0)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$19.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001193125-26-116164. Derived: 12-month figure less the 9-month figure.Report this figure(16.1)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$16.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001193125-26-221702.Report this figure(17.7)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$17.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349314. Derived: 6-month figure less the 3-month figure.Report this figure(14.5)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$14.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001193125-25-283275. Derived: 9-month figure less the 6-month figure.Report this figure(14.1)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$14.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001193125-26-116164. Derived: 12-month figure less the 9-month figure.Report this figure(22.6)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$22.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001193125-26-221702.Report this figure(22.7)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$22.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349314. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)113.63m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares14.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3014,265,905 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-062203.Report this figure14.3Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3114,285,905 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q/A filed 2024-08-19, accession 0000950170-24-098582.Report this figure24.0Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3024,006,549 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-19, accession 0000950170-24-098590.Report this figure30.0Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3029,974,400 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-125622.Report this figure30.0Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3129,989,400 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q/A filed 2025-08-14, accession 0001193125-25-180904.Report this figure42.3Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3042,278,411 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001193125-25-180906.Report this figure55.5Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3055,478,342 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figure77.1Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3177,126,763 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001193125-26-221702.Report this figure77.2Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3077,156,068 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure77.2Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3077,156,068 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001193125-25-283275.Report this figure112Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31112,424,211 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001193125-26-221702.Report this figure114Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30113,631,565 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure

Shares outstanding: 81.26mShares outstanding, period not labelled, at 2026-08-1081,261,152 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349314.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.